Shp2 confers cisplatin resistance in small cell lung cancer via an AKT-mediated increase in CA916798-Reference-Cited by-全球学者库

登录注册会员服务联系我们

Shp2 confers cisplatin resistance in small cell lung cancer via an AKT-mediated increase in CA916798

Published:2017-02-23 Issue:14 Volume:8 Page:23664-23674
ISSN:1949-2553
Container-title:Oncotarget
language:en
Short-container-title:Oncotarget

Author:

Yang Xuemei¹²,Tang Chunlan¹,Luo Hu¹,Wang Haijing¹,Zhou Xiangdong¹

Affiliation:

1. Department of Respiratory, Southwest Hospital, Third Military Medical University, Shapingba District, Chongqing 400038, PR China

2. Department of Respiratory, Institute of Surgery Research, Daping Hospital, Third Military Medical University, Yuzhong District, Chongqing 400042, PR China

Publisher

Impact Journals, LLC

Subject

Oncology

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Overcoming Immune Checkpoint Therapy Resistance with SHP2 Inhibition in Cancer and Immune Cells: A Review of the Literature and Novel Combinatorial Approaches;Cancers;2023-11-13

2. CA916798 predicts poor prognosis and promotes Gefitinib resistance for lung adenocarcinoma;BMC Cancer;2023-03-23

3. Roles of protein tyrosine phosphatases in hepatocellular carcinoma progression (Review);Oncology Reports;2023-01-19

4. A comprehensive review of SHP2 and its role in cancer;Cellular Oncology;2022-09-06

5. Critical roles of PTPN family members regulated by non-coding RNAs in tumorigenesis and immunotherapy;Frontiers in Oncology;2022-07-26

全球学者库

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"全球学者库"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前全球学者库共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP